Counterattacking drug-resistant tuberculosis: molecular strategies and future directions

Elimination of intracellularly residingMycobacterium tuberculosisthrough targeting of host and bacterial signaling mechanisms

(2012) Rajesh Jayachandran et al.   Expert Review of Anti-Infective Therapy

Strategies for potentiation of ethionamide and folate antagonists againstMycobacterium tuberculosis

(2012) Kerstin A Wolff et al.   Expert Review of Anti-Infective Therapy

Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs

(2012) Miguel Viveiros et al.   Expert Review of Anti-Infective Therapy

Targeting the mycobacterial envelope for tuberculosis drug development

(2012) Lorenza Favrot et al.   Expert Review of Anti-Infective Therapy

WhiB7, a transcriptional activator that coordinates physiology with intrinsic drug resistance inMycobacterium tuberculosis

(2012) Ján Burian et al.   Expert Review of Anti-Infective Therapy

Targeting the global regulator Lsr2 as a novel approach for anti-tuberculosis drug development

(2012) Jun Liu et al.   Expert Review of Anti-Infective Therapy

Targeting drug tolerance in mycobacteria: a perspective from mycobacterial biofilms

(2012) Mohammad S Islam et al.   Expert Review of Anti-Infective Therapy

MDR, XDR, TDR tuberculosis: ominous progression

(2012) Zarir F Udwadia   THORAX

Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism

(2011) Kristin N. Adams et al.   CELL

Susceptibility of Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and their combination over a 12 year period in Taiwan

(2011) T.-S. Huang et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antibiotic resistance is ancient

(2011) Vanessa M. D’Costa et al.   NATURE

Mycobacterium tuberculosis and Sulfamethoxazole Susceptibility

(2010) W. Ong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Short History of Dapsone, or an Alternative Model of Drug Development

(2010) J. Barr   JOURNAL OF THE HISTORY OF MEDICINE AND ALLIED SCIENCES

Tuberculosis and Trimethoprim-Sulfamethoxazole

(2009) P. Forgacs et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synthetic EthR inhibitors boost antituberculous activity of ethionamide

(2009) Nicolas Willand et al.   NATURE MEDICINE

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis

(2009) J.-E. Hugonnet et al.   SCIENCE

A synthetic mammalian gene circuit reveals antituberculosis compounds

(2008) W. Weber et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA